IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ONIDA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.727
NA - Nord America 9.780
AS - Asia 4.881
SA - Sud America 284
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 14
Totale 34.783
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.476
DE - Germania 8.310
GB - Regno Unito 5.804
CN - Cina 2.398
IT - Italia 1.480
SE - Svezia 993
SG - Singapore 720
UA - Ucraina 640
RU - Federazione Russa 544
IN - India 449
IE - Irlanda 401
KR - Corea 381
FR - Francia 367
TR - Turchia 348
EU - Europa 307
CA - Canada 280
FI - Finlandia 252
NL - Olanda 244
ES - Italia 214
CO - Colombia 170
JP - Giappone 137
DK - Danimarca 135
HK - Hong Kong 119
ID - Indonesia 94
BR - Brasile 76
TW - Taiwan 66
AU - Australia 61
BE - Belgio 61
CH - Svizzera 53
GR - Grecia 44
PL - Polonia 41
AT - Austria 36
TH - Thailandia 27
UZ - Uzbekistan 27
IL - Israele 21
IR - Iran 19
PH - Filippine 18
AR - Argentina 17
PT - Portogallo 17
RO - Romania 17
CZ - Repubblica Ceca 16
NO - Norvegia 16
MX - Messico 14
VN - Vietnam 14
NZ - Nuova Zelanda 13
BG - Bulgaria 9
SK - Slovacchia (Repubblica Slovacca) 9
MY - Malesia 8
SA - Arabia Saudita 8
CL - Cile 7
EG - Egitto 7
PK - Pakistan 7
HU - Ungheria 6
PE - Perù 6
HR - Croazia 4
LK - Sri Lanka 4
AL - Albania 3
BO - Bolivia 3
DZ - Algeria 3
GT - Guatemala 3
KW - Kuwait 3
KZ - Kazakistan 3
LT - Lituania 3
BD - Bangladesh 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
GL - Groenlandia 2
LB - Libano 2
RS - Serbia 2
UY - Uruguay 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BY - Bielorussia 1
EE - Estonia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KY - Cayman, isole 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
SI - Slovenia 1
VE - Venezuela 1
Totale 35.068
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 7.034
Southend 5.263
Boise 1.203
Chandler 852
Beijing 712
Seattle 697
Jacksonville 617
Milan 483
Singapore 468
Wilmington 466
Princeton 464
Ashburn 405
Dublin 393
Fairfield 299
Nanjing 262
Redmond 247
Woodbridge 203
Serra 191
Dearborn 185
Mountain View 184
Des Moines 170
Bengaluru 167
Ann Arbor 161
Munich 159
Andover 155
Sakarya 154
Houston 152
Bogotá 148
Redwood City 147
Boardman 146
Shanghai 134
Mcallen 112
Toronto 107
Jinan 106
Cambridge 102
Montréal 99
Somerville 98
Payette 93
Berlin 85
Guangzhou 82
Nanchang 81
Shenyang 81
New York 80
Garden Valley 72
Hebei 67
Hong Kong 64
Tianjin 57
Hangzhou 56
Jerome 56
Bitonto 53
Lewiston 53
Helsinki 52
Orofino 51
Changsha 50
Santa Clara 47
Phoenix 46
Margão 45
Cottonwood 42
Taipei 42
Eitensheim 41
Jakarta 41
Pisa 38
San Diego 38
Kunming 37
Paris 37
Saint Petersburg 37
Tokyo 36
London 35
Auburn Hills 34
Rome 34
Los Angeles 33
Hefei 32
Zhengzhou 32
Barcelona 31
Brussels 31
Jiaxing 31
Athens 29
Madrid 29
The Dalles 29
São Paulo 27
Turin 27
Verona 27
Haikou 26
Kwai Chung 24
Grafing 23
Kiez 23
Hyderabad 22
Vienna 22
Ottawa 21
Falls Church 20
Fremont 19
Hamburg 19
Ningbo 19
Sydney 19
Roxbury 18
Washington 18
Fuzhou 17
Hanover 17
Istanbul 17
Lanzhou 17
Totale 25.427
Salva come PNG Salva come JPEG
Nome #
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial 981
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome : A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) 959
Acquired in-vitro resistance to STI571 (Imatinib mesylate) in BCR/ABL-positive cell lines: investigation of gene expression by molecular pathway microarrays 890
In-vitro effects of STI571 (Imatinib mesylate) in BCR/ABL-positive cell lines : modulation of gene expression assessed by pathway microarrays 876
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies 580
Single institution retrospective analysis of bronchoalveolar lavage as etiological diagnostic tool for pulmonary infiltrates in patients with haematological malignancies 396
Autologous hematopoetic stem cell transplantation for refractory Crohn disease a randomized clinical trial 343
Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's Disease : a review on behalf of ECCO and EBMT 335
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience 316
RAS mutations vontribute to evolution of chronic myelomonocytic leukemia to the proliferative variant 308
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee 294
Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. 280
Long-term clinical and molecular outcomes following RIC-allogeneic HSCT from HLA-identical sibling in patients with advanced mycosis fungoides and Sézary syndrome 262
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 261
Allogeneic hematopoietic stem cell transplantation for MDS and CMML : recommendations from an international expert panel 249
Activity of sphingosine kinase inhibitor in Chronic Myelogenous Leukemia cells sensitive and resistant to Imatinib Mesylate 243
TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome 237
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease 228
Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease 223
Indolent B-cell lymphomas treated upfront with antiviral therapy : a series of 13 patients 211
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up with unselected stem cells 209
Evolving pattern of microbial susceptibility to antibiotics in a HSCT unit 208
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up without CD34+ cell selection 206
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 205
Proposed diagnostic criteria for classical CMML, CMML variants and pre-CMML conditions 203
Impact of Cytogenetics on Outcome of Patients with MDS or Secondary AML Undergoing Allogeneic HSCT from HLA-identical Siblings : a Retrospective Analysis of the EBMT-CLWP 198
Analisys of bone marrow hematopoietic and mesenchymal precursors in patients with amyotrophic lateral sclerosis 195
Analysis of T-cell receptor rearrangements and microarrays in pediatric patients with cutaneous lymphoma 192
Autologous haematopoietic stem cell transplantation for Crohn's disease : a retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation 191
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome : a study from the Gruppo Italiano Trapianto di Midollo Osseo(GITMO) 189
Array-based comparative genomic hybridization analysis of aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (AECD8+L), extranodal NK/T nasal type lymphoma (ENK/T-NT) and blastic plasmocytoid dendritic cell neoplasia (BPDCN) 188
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet 188
Retrospective analysis of salvage regimen for relapsed or refractory classical Hodgkin lymphoma 186
Functional alteration of bone marrow mesenchymal stem cells of Amyotrophic Lateral Sclerosis Patients 185
Evaluation of deoxycholate amphotericin-B toxicity after HSCT 183
Non-myeloablative allografting for newly diagnosed multiple myeloma : the experience of the Gruppo Italiano Trapianti di Midollo. 181
Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome 177
Evolution of empirical antifungal therapy in a bone marrow transplantation unit 176
Chronic myelomonocytic leukemia : identification of molecular abnormalities and monitoring of ras mutations-driven disease progression by allele-specific PCR 176
Autologous haematopoietic unselected peripheral blood stem cell transplantation in refractory Crohn's disease: up to 2-years follow-up of a phase I-II trial 175
Comparison of Allogeneic Stem Cell Transplantation and Non-Transplant Approaches in Elderly Patients with Advanced Myelodysplastic Syndrome : Optimal Statistical Approaches and a Critical Appraisal of Clinical Results Using Non-Randomized Data 175
Amyotrophic Lateral Sclerosis Bone Marrow Characterization 174
Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) versus Thalidomide-Dexamethasone to treat multiple myeloma (MM) patients progressing or relapsing after autologous transplantation : the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia Working Party of the EBMT 173
In vitro effect of second mitochondria-derived activator of caspases (SMAC) mimic compounds on myeloid leukemia cell lines 173
La formazione pre-laurea sulle cure palliative presso l'Università degli Studi di Milano 173
Autologous haematopoietic stem cell transplantation for refractory Crohn’s disease: updating the Milan experience without CD34+ cell selection 172
Metalloproteinase alterations in the bone marrow of ALS patients 172
Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant from the Same Donor with No Immunosuppression but C5 Inhibition 172
Human bone marrow mesenchymal stem cells transplantation in 6-hydroxydopamine-lesioned rodents 170
Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report 169
Isolation and characterization of L-NGFR(+) mesenchymal stem cells from adipose tissue and bone marrow: a comparison between the two sources 166
Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells : mechanistic studies of Smac mimetic 166
Sphingosine kinase 1 as a potential target to inhibit proliferation of myeloid leukemia cells 165
Allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia with 17p Deletion: a retrospective EBMT analysis. 164
Autologous non- myeloablative haematopoietic stem cell transplantation without CD34+selection for refractory Crohn's disease: the Milan experience after 5 years 164
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review 162
Hyperleptinaemia in long-term transplant survivors with metabolic syndrome 162
HLA-Identical Allogeneic Stem Cell Transplantation (alloSCT) for Patients with Primary Cutaneous T-Cell Lymphoma (CTCL): A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT-LWP) 161
High Frequency of Tumor Suppressor Genes Promoter Hypermethylation in Peripheral Blood of Patients with Myelodysplastic Syndromes 161
Bortezomib (Velcade)-thalidomide-dexamethasone (VTD) is superior to thalidomide-dexamethasone (TD) in patients with multiple myeloma (MM) progressing or relapsing after autologous transplantation 161
Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients 160
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD34+ cells selection 158
Effect of Second Mitochondria-Derived Activator of Caspases (Smac) Mimetic Compounds on Leukemic Cell Lines 158
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sézary syndrome 157
Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies 157
Sphingolipids players in the leukemia arena 156
Second mitochondria-derived activator of caspases mimetic compounds (Smac) enhance tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) pro-Apoptotic effect on human myeloid leukemia cell lines 155
Mesenchymal stem cells fron bone marrow of patients with Systemic Sclerosis : properties and pathogenic perspectives 155
Biological characterization of hematopoietic and mesenchymal stem cell compartments in sporadic Amyotrophic Lateral Sclerosis 154
Autologous stem cell transplantation in Crohn's disease 153
Second malignancies in essential thrombocytosis: a retrospective analysis of 331 patients from a single institution (Abs. P351) 151
Diagnosis and Management of Chronic Myelomonocytic Leukemia 150
Autologous hematopoietic stem cell transplantation : a successful treatment for early severe systemic sclerosis 149
Comparison between spontaneously occurring and post-transplant metabolic syndrome 149
Prognostic impact of pretransplantation transfusion-dependency and serum ferritin level in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation : a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 149
In vitro anti-leukaemia activity of sphingosine kinase inhibitor 148
Immunomodulatory effects of autologous stem cell transplantation in refractory Cronh’s disease : updatring the Milan experience without CD34+ cell selection 146
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 145
Chronic myelomonocytic leukemia in younger patients : molecular and cytogenetic predictors of survival and treatment outcome 145
Biological and molecular differences between the dysplastic and the proliferative variants of chronic myelomonocytic leukemia 144
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate 144
Autologous stem cell transplantation for Crohn’s disease trial : early report of toxicity and efficacy 144
Preliminary monocentric survey on the prevalence of HBV seropositivity in HSCT recipients 144
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD 34+ cells selection 142
A prospective phase II study on tandem autografting-nonmyeloablative allografting for newly diagnosed myeloma : final results of the Gruppo Italiano Trapianto Midollo Osseo 142
Unrelated mismatched cord blood transplantation in an adult with secondary AML 141
Incidence and predictive factors of hepatic veno-occlusive disease after bone marrow transplantation 141
HLA-identical allogeneic stem cell transplantation for patients with primary cutaneous T-cell lymphoma : a retrospective analysis of the Lymphoma Working Party of the European Blood and Marrow Transplantation Group 141
Autologous stem cell transplantation in moderate-severe refractory Crohn's disease : the Milan experience without CD34+ cells selection 140
Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL) 140
Reduced versus standard conditioning followed by allogeneic stem cell transplantation in MDS/sAML. A prospective randomised phase III study of the MDS subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplant 139
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis 139
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R 139
Pegylated G-CSF after autologous hematopoietic stem cell transplantation 138
WHO Classification and WPSS Score Predict Post-Transplant Outcome in Adults with Myelodysplastic Syndrome : A Retrospective Study by GITMO - Gruppo Italiano Trapianto Midollo Osseo 138
Presence of CD34+cells in the CSF after G-CSF induced mobilisation and mannitol treatment in patients with amyotrophic lateral sclerosis 137
Blastic plasmacytoid dendritic cell neoplasm : clinical, immunohistochemical and molecular evaluation of 23 cases with primary cutaneous involvement 137
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 136
Autologous hematopoietic stem cell transplantation in early severe systemic sclerosis 136
PRO-APOPTOTIC EFFECT OF A NEW SMAC-MIMETIC ON B-CLL CELLS IN VITRO 135
Totale 21.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.242 0 0 0 421 285 515 351 362 523 503 209 73
2020/20213.557 221 281 303 63 288 246 224 205 459 189 893 185
2021/20222.341 177 96 110 117 147 132 268 170 300 218 106 500
2022/20233.113 388 256 248 287 414 610 87 211 285 59 146 122
2023/20247.273 93 197 150 189 553 348 991 905 434 978 1.161 1.274
2024/20253.511 1.114 1.102 1.037 258 0 0 0 0 0 0 0 0
Totale 36.629